BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26544585)

  • 1. Clinical relevance of cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.
    Lin KY; Hung CC
    AIDS; 2015 Oct; 29(16):2213-4. PubMed ID: 26544585
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.
    Buijs BS; van den Berk GE; Boateng CP; Hoepelman AI; van Maarseveen EM; Arends JE
    AIDS; 2015 Apr; 29(7):785-91. PubMed ID: 25985401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of HIV drug hypersensitivity.
    Davis CM; Shearer WT
    J Allergy Clin Immunol; 2008 Apr; 121(4):826-832.e5. PubMed ID: 18190954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restarting trimethoprim-sulfamethoxazole after a hypersensitivity reaction in patients infected with the human immunodeficiency virus.
    Everson-Mays RE; Weidle PJ
    Am J Health Syst Pharm; 1997 Jul; 54(13):1545-50. PubMed ID: 9217946
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of darunavir hypersensitivity in different clinical cohorts.
    Arends JE; van den Berk GE
    AIDS; 2015 Oct; 29(16):2214-5. PubMed ID: 26544586
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone is often tolerated in HIV-infected patients with history of sulfonamide antibiotic intolerance.
    May SM; Motosue MS; Park MA
    J Allergy Clin Immunol Pract; 2017; 5(3):831-833. PubMed ID: 28034550
    [No Abstract]   [Full Text] [Related]  

  • 7. Trimethoprim/sulfamethoxazole: clinical update.
    Libecco JA; Powell KR
    Pediatr Rev; 2004 Nov; 25(11):375-80. PubMed ID: 15520082
    [No Abstract]   [Full Text] [Related]  

  • 8. Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis.
    Le Meur L; Tantet C; Lê MP; Desselas E; Bonnal C; Lillo-Le-Louet A; Sonneville R; Massias L; Giraud J; Descamps D; Yazdanpanah Y; Lariven S; Peytavin G
    J Antimicrob Chemother; 2018 Apr; 73(4):1108-1110. PubMed ID: 29294026
    [No Abstract]   [Full Text] [Related]  

  • 9. Trimethoprim-Sulfamethoxazole-associated Fulminant Respiratory Failure in Children and Young Adults.
    Miller JO; Shih AR; Mino-Kenudson M; Taylor MS; Goldman JL
    Am J Respir Crit Care Med; 2021 Apr; 203(7):918-921. PubMed ID: 33513317
    [No Abstract]   [Full Text] [Related]  

  • 10. Glutathione in hypersensitivity to trimethoprim/sulfamethoxazole in patients with HIV infection.
    Rose EW; McCloskey WW
    Ann Pharmacother; 1998 Mar; 32(3):381-3. PubMed ID: 9533069
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients.
    Wang D; Curtis A; Papp AC; Koletar SL; Para MF
    BMC Med Genomics; 2012 Jul; 5():32. PubMed ID: 22824134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced hypersensitivity syndrome after initiation of darunavir and raltegravir.
    Eyer-Silva WA; Freire MAL; Silva GARD
    Rev Soc Bras Med Trop; 2017; 50(4):575-576. PubMed ID: 28954087
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
    Piketty C; Gilquin J; Kazatchkine MD
    J Infect Dis; 1995 Aug; 172(2):611. PubMed ID: 7622921
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical Severe Shock-like Reactions in Adolescents After Trimethoprim-Sulfamethoxazole Therapy.
    Rathe JA; Poole N; Melvin A
    J Pediatric Infect Dis Soc; 2021 Apr; 10(3):382-385. PubMed ID: 32955095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity reactions to drugs in HIV-infected patients. Allergic evaluation and desensitization.
    Moreno-Ancillo A; López-Serrano MC
    Clin Exp Allergy; 1998 Sep; 28 Suppl 4():57-60. PubMed ID: 9761034
    [No Abstract]   [Full Text] [Related]  

  • 16. Trimethoprim-sulfamethoxazole-induced drug reaction with eosinophilia and systemic symptoms in a child with congenital renal disease.
    Maarouf M; Wickenheiser M; Krase JM; Wolter S; Shi VY
    Pediatr Dermatol; 2018 Nov; 35(6):e391-e392. PubMed ID: 30187970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug interactions between voriconazole, darunavir/ritonavir and tenofovir/emtricitabine in an HIV-infected patient treated for Aspergillus candidus lung abscess.
    Becker A; Sifaoui F; Gagneux M; Desprez S; Vignoli P; Huguet D; Froidure M; Leduc D; Legout L
    Int J STD AIDS; 2015 Aug; 26(9):672-5. PubMed ID: 25179636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic Allergy Labels in a Liver Transplant Recipient Study.
    Khumra S; Chan J; Urbancic K; Worland T; Angus P; Jones R; Grayson ML; Trubiano JA
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264847
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection.
    Rieder MJ; King SM; Read S
    Pediatr Infect Dis J; 1997 Nov; 16(11):1028-31. PubMed ID: 9384334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-Associated Toxic Epidermal Necrolysis at San Francisco General Hospital.
    Tseng J; Maurer T; Mutizwa MM
    J Int Assoc Provid AIDS Care; 2017; 16(1):37-41. PubMed ID: 26685211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.